Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other financing activities (2016 - 2024)

Historic Other financing activities for Mimedx (MDXG) over the last 8 years, with Q1 2024 value amounting to $1.1 million.

  • Mimedx's Other financing activities changed N/A to $1.1 million in Q1 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 221730.77%. This contributed to the annual value of $1.1 million for FY2024, which is 221730.77% up from last year.
  • As of Q1 2024, Mimedx's Other financing activities stood at $1.1 million.
  • Over the past 5 years, Mimedx's Other financing activities peaked at $6.5 million during Q3 2020, and registered a low of -$52000.0 during Q4 2023.
  • In the last 3 years, Mimedx's Other financing activities had a median value of $1.0 million in 2020 and averaged $2.1 million.
  • The largest annual percentage gain for Mimedx's Other financing activities in the last 5 years was 896000.0% (2020), contrasted with its biggest fall of 99932.77% (2020).
  • Over the past 3 years, Mimedx's Other financing activities (Quarter) stood at $906000.0 in 2020, then tumbled by 105.74% to -$52000.0 in 2023, then surged by 2217.31% to $1.1 million in 2024.
  • Its last three reported values are $1.1 million in Q1 2024, -$52000.0 for Q4 2023, and $906000.0 during Q4 2020.